Your browser doesn't support javascript.
loading
First Clinical Experience with ONO-4232: A Randomized, Double-blind, Placebo-controlled Healthy Volunteer Study of a Novel Lusitropic Agent for Acutely Decompensated Heart Failure.
Ward, Caroline L; Jamieson, Virginia; Nabata, Toshiya; Sharpe, John; Dozono, Koji; Suto, Fumitaka; Hashimoto, Yoshitaka; Gussak, Ihor.
Afiliación
  • Ward CL; EU/US Drug Development, ONO Pharma UK LTD, London, United Kingdom. Electronic address: t-nabata@ono-uk.co.uk.
  • Jamieson V; EU/US Drug Development, ONO Pharma UK LTD, London, United Kingdom.
  • Nabata T; EU/US Drug Development, ONO Pharma UK LTD, London, United Kingdom.
  • Sharpe J; EU/US Drug Development, ONO Pharma UK LTD, London, United Kingdom.
  • Dozono K; EU/US Drug Development, ONO Pharma UK LTD, London, United Kingdom.
  • Suto F; Translational Medicine Center, Ono Pharmaceuticals Co Ltd, Osaka, Japan.
  • Hashimoto Y; EU/US Drug Development, ONO Pharma UK LTD, London, United Kingdom.
  • Gussak I; Gussak Consulting LLC, Morristown, New Jersey.
Clin Ther ; 38(5): 1109-21, 2016 05.
Article en En | MEDLINE | ID: mdl-27001444

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fármacos Cardiovasculares Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Ther Año: 2016 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fármacos Cardiovasculares Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Ther Año: 2016 Tipo del documento: Article Pais de publicación: Estados Unidos